Skip to Main Content

VirusIQ Screening Platform > Virtual Lab Module

The COVID-19 pandemic is a healthcare data goldrush at present which raises concerns as to the future unintended consequences of the sensitive health information that may be shared to address a temporary crisis. We recognise the need throughout the digital transformation to not lose sight of centuries of evolution of ethics and principles such as privacy, security, confidentiality when developing systems that may transform patient engagement.

VirusIQ is an inclusive digital to provide universal and equitable pandemic response. For the designathon we propose in this instance to work collaboratively with the HHS Protect, to develop a combined hardware-software solution for the computation and communication of laboratory test data via the remote VirusIQ screening platform.

The VirusIQ screening platform modules include; digital health identity & passport, symptom data collection, screening risk analytics, public Health and Education, telemedicine, virtual laboratory, contact tracing, US FDA Real-time data analytics 

We propose as part of our VLA module, a cellular chip, designed and prototyped to capture, standardize and report data to the VirusIQ WATER system. The WATER system will be developed to interface and set the design parameters for all devices to directly report data into HHS Protect.

5 min Video of Capstone Project

Elevator Pitch

The VirusIQ screening platform is an infectious diseases management modular system. We present the virtual lab software-hardware module. 

Challenge Goals

The Design-a-thon products will be built through direct platform integration or as companions that are part of the testing workflow, thus relieving users from manual data entry and reporting for diagnostic data elements.

Patient-related data elements (e.g. demographic data) is input from the patient or provider, combined with diagnostic data elements, and then automatically pushed to the appropriate public health authorities by the IVD platform/test system.

Wireless Automated Transmission for Electronic Reporting Systems (WATERS)will be built during the Design-a-thon as the "back-end processing" or "docking station" that interfaces and sets the design parameters for all devices to directly report data into HHS Protect.

Feasibility

Week 1 - commence the TOPx project

Week 1 to 4 - develop automated data pipelines and WATERS platform. 

Week 1 to 4 - design the Lab Chip and fabricate prototype

Week 4 to 6 - implement, test and integrate WATERS with HHS docker

Week 4 to 6 - achieve ISO 27001 security compliance

Week 4 to 6 - launch WATERS platform when ready

Week 6 to 12 - monitor and upgrade as required, integrate with third party entities (e.g. AIMS, HIE, PHA)

Week 6 to 12 - Pilot VirusIQ virtual lab system with Chips embedded in diagnostic devices

Week 12 - 24 - WATERS system updates, scale and distribute VLA system

Week 24 - HITRUST security certification

Design

Hardware solution > VirusIQ virtual lab chip which can be embedded into any diagnostic test (laboratory or at-home device). VirusIQ chip for diagnostic test reader is designed with edge computing capabilities and data communication capabilities to plugin with the existing testing devices. This chip is similar to a GSM chip thus does not require an internet connection to transmit data. This chip will also apply the data de-identification, unique ID generation, encryption using designated VirusIQ WATERs system and send the data over the cellular network in HL7 messaging format.

Software Solution > WATERS platform uses automated data pipelines, a rules engine for legal, privacy, cryptography, taxonomy and messaging standards.

Innovation

Hardware > a proprietary chip designed to be embedded in any diagnostic device that is capable of computation and communication without the internet. 

Software > use of data pipeline automation for efficient and secure data transmission. Use of innovative data security architecture. The system also uses algorithms to efficiently manage diagnostic test data and supply chain information. 

Flexibility & Scalability

Our platform uses HL7 FHIR messaging standards in addition to others used by existing platforms using an automated process for selection. We will consider building a transforming connector if necessary. 

The platform supports data analytics to enhance utility for multiple different government and business stakeholders. 

The automation of the inclusive platform and the agnostic chip enables high scalability and relatively lower costs to enable maximum nation-wide impact. 

Sustainability & Extensibility

The hardware chip that can work without internet connection enhances security of test devices and further can be embedded in any device. The firmware can be upgraded to ensure sustainability and extensibility as new innovative technologies are developed, for COVID and beyond. 

We are designing our platform as an infectious disease management and biosecurity solution to not only help with the current pandemic but also to service future pandemics. 

Depending on security requirements we could enable some of the software components to be open-source to enhance community-led innovation for the future. 

 

Team & Collaboration

Our team are experts from the relevant specialist medical, legal, policy, engineering, security, and scientific community. 

Please see attached PDF for relevant representation of team members.

We presently collaborate with a number of technology and distribution partners and welcome any invitations for collaboration, strategic partnerships and funding. 

Additional Comments

Please see attached PDF for a detailed proposal. 

What Team(s) contributed to this Capstone Project?

VirusIQ

If you are using patient data, are you using real patient data or mock data? Please use MOCK patient data only

No answer chosen

edited on Nov 30, 2020 by Valeria Rodriguez
You will need to login to post a comment

Sophia B Liu 7 months ago

This idea has been advanced to the current phase

People's Choice Voting Extended

Reply 0

Brian Hough 7 months ago

Hi Sophia, it looks like there's two duplicate entries for this team, so I didn't know which one to vote for. Can you merge the two? The team might get more points if they're merged. Here's a link to the other page: https://waters.crowdicity.com/post/695466

Users tagged:

Reply 0

Sophia B Liu 7 months ago

This idea has been advanced to the next phase

People's Choice Voting Extended

Reply 0

Andrea Pitkus 7 months ago

Trying to understand if there are preconditions met by other software. (In general) 1. How to collect AOEs, from ordering provider/patient/specimen collector 2. Integrate into app/LIS or other information source for patient to be married to results of IVD test device/system 3. All transmitted to public health (ELR) 4. All transmitted to HHS (may be met by 3).

Will your approach support all 4 or only portions of above for "tracking lab results"? (Looks like the chip runs in parallel to some of these)

Looks like you support LIS based reporting of ELR in HL7 v2.51 (per the MU IG)? For patient performed results are they routed to the physician who is required to report via electronic Case Reporting (eCR) by law? How would your approach support LISs or labs that don't have API functionality?

Are LOINC, SNOMED CT and other codes systems supported at the point of origin or downstream as in your diagram to meet requirements?

How are CLIA testing requirements met in your system?

Curious more about the chip and how it would "automatically" collect patient performed test results like the recent Lucira EUA? How about for Antigen or Antibody card (like pregnancy tests). How does the chip read the result values and assign appropriate LOINC and SNOMED CT codes depending on the results/values for appropriate transmission to the provider and public health? How are AOEs and other patient provided info collected on the chip? How is the chip CLIA validated for use in laboratories/Point of Care testing scenarios as in the Lucira EUA?

Intriguing proposal!!

Reply 0

Share